Global Dermatological Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 147655
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 135
  • list Pharmaceuticals and Healthcare

Scope of the Report:

This report focuses on the Dermatological Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Dermatological Therapeutics is expected to grow at a CAGR of roughly 7.7% over the next five years, will reach 83 million US$ in 2023, from 53 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

AGI Dermatics

Allergan

Amgen

Chester Valley

Dermik

Eisai

Ferndale

Genentech

Medicis

Onset Therapeutics

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Anti-infectives 

Corticosteroids

Anti Psoriasis

Anti-acne 

Others

Market Segment by Applications, can be divided into

Hospital

Clinic

There are 15 Chapters to deeply display the global Dermatological Therapeutics market.

Chapter 1, to describe Dermatological Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Dermatological Therapeutics, with sales, revenue, and price of Dermatological Therapeutics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Dermatological Therapeutics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Dermatological Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Dermatological Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Dermatological Therapeutics Introduction

1.2 Market Analysis by Type

1.2.1 Anti-infectives 

1.2.2 Corticosteroids

1.2.3 Anti Psoriasis

1.2.4 Anti-acne 

1.2.5 Others

1.3 Market Analysis by Applications

1.3.1 Hospital

1.3.2 Clinic

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 AGI Dermatics

2.1.1 Business Overview

2.1.2 Dermatological Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 AGI Dermatics Dermatological Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Allergan

2.2.1 Business Overview

2.2.2 Dermatological Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Allergan Dermatological Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Amgen

2.3.1 Business Overview

2.3.2 Dermatological Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Amgen Dermatological Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Chester Valley

2.4.1 Business Overview

2.4.2 Dermatological Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Chester Valley Dermatological Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Dermik

2.5.1 Business Overview

2.5.2 Dermatological Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Dermik Dermatological Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Eisai

2.6.1 Business Overview

2.6.2 Dermatological Therapeutics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Eisai Dermatological Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Ferndale

2.7.1 Business Overview

2.7.2 Dermatological Therapeutics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Ferndale Dermatological Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Genentech

2.8.1 Business Overview

2.8.2 Dermatological Therapeutics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Genentech Dermatological Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Medicis

2.9.1 Business Overview

2.9.2 Dermatological Therapeutics Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Medicis Dermatological Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Onset Therapeutics

2.10.1 Business Overview

2.10.2 Dermatological Therapeutics Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Onset Therapeutics Dermatological Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Dermatological Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Dermatological Therapeutics Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Dermatological Therapeutics Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Dermatological Therapeutics Manufacturer Market Share in 2017

3.3.2 Top 6 Dermatological Therapeutics Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Dermatological Therapeutics Market Analysis by Regions

4.1 Global Dermatological Therapeutics Sales, Revenue and Market Share by Regions

4.1.1 Global Dermatological Therapeutics Sales and Market Share by Regions (2013-2018)

4.1.2 Global Dermatological Therapeutics Revenue and Market Share by Regions (2013-2018)

4.2 North America Dermatological Therapeutics Sales and Growth Rate (2013-2018)

4.3 Europe Dermatological Therapeutics Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Dermatological Therapeutics Sales and Growth Rate (2013-2018)

4.5 South America Dermatological Therapeutics Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Dermatological Therapeutics Sales and Growth Rate (2013-2018)

5 North America Dermatological Therapeutics by Countries

5.1 North America Dermatological Therapeutics Sales, Revenue and Market Share by Countries

5.1.1 North America Dermatological Therapeutics Sales and Market Share by Countries (2013-2018)

5.1.2 North America Dermatological Therapeutics Revenue and Market Share by Countries (2013-2018)

5.2 United States Dermatological Therapeutics Sales and Growth Rate (2013-2018)

5.3 Canada Dermatological Therapeutics Sales and Growth Rate (2013-2018)

5.4 Mexico Dermatological Therapeutics Sales and Growth Rate (2013-2018)

6 Europe Dermatological Therapeutics by Countries

6.1 Europe Dermatological Therapeutics Sales, Revenue and Market Share by Countries

6.1.1 Europe Dermatological Therapeutics Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Dermatological Therapeutics Revenue and Market Share by Countries (2013-2018)

6.2 Germany Dermatological Therapeutics Sales and Growth Rate (2013-2018)

6.3 UK Dermatological Therapeutics Sales and Growth Rate (2013-2018)

6.4 France Dermatological Therapeutics Sales and Growth Rate (2013-2018)

6.5 Russia Dermatological Therapeutics Sales and Growth Rate (2013-2018)

6.6 Italy Dermatological Therapeutics Sales and Growth Rate (2013-2018)

7 Asia-Pacific Dermatological Therapeutics by Countries

7.1 Asia-Pacific Dermatological Therapeutics Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Dermatological Therapeutics Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Dermatological Therapeutics Revenue and Market Share by Countries (2013-2018)

7.2 China Dermatological Therapeutics Sales and Growth Rate (2013-2018)

7.3 Japan Dermatological Therapeutics Sales and Growth Rate (2013-2018)

7.4 Korea Dermatological Therapeutics Sales and Growth Rate (2013-2018)

7.5 India Dermatological Therapeutics Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Dermatological Therapeutics Sales and Growth Rate (2013-2018)

8 South America Dermatological Therapeutics by Countries

8.1 South America Dermatological Therapeutics Sales, Revenue and Market Share by Countries

8.1.1 South America Dermatological Therapeutics Sales and Market Share by Countries (2013-2018)

8.1.2 South America Dermatological Therapeutics Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Dermatological Therapeutics Sales and Growth Rate (2013-2018)

8.3 Argentina Dermatological Therapeutics Sales and Growth Rate (2013-2018)

8.4 Colombia Dermatological Therapeutics Sales and Growth Rate (2013-2018)

9 Middle East and Africa Dermatological Therapeutics by Countries

9.1 Middle East and Africa Dermatological Therapeutics Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Dermatological Therapeutics Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Dermatological Therapeutics Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Dermatological Therapeutics Sales and Growth Rate (2013-2018)

9.3 UAE Dermatological Therapeutics Sales and Growth Rate (2013-2018)

9.4 Egypt Dermatological Therapeutics Sales and Growth Rate (2013-2018)

9.5 Nigeria Dermatological Therapeutics Sales and Growth Rate (2013-2018)

9.6 South Africa Dermatological Therapeutics Sales and Growth Rate (2013-2018)

10 Global Dermatological Therapeutics Market Segment by Type

10.1 Global Dermatological Therapeutics Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Dermatological Therapeutics Sales and Market Share by Type (2013-2018)

10.1.2 Global Dermatological Therapeutics Revenue and Market Share by Type (2013-2018)

10.2 Anti-infectives  Sales Growth and Price

10.2.1 Global Anti-infectives  Sales Growth (2013-2018)

10.2.2 Global Anti-infectives  Price (2013-2018)

10.3 Corticosteroids Sales Growth and Price

10.3.1 Global Corticosteroids Sales Growth (2013-2018)

10.3.2 Global Corticosteroids Price (2013-2018)

10.4 Anti Psoriasis Sales Growth and Price

10.4.1 Global Anti Psoriasis Sales Growth (2013-2018)

10.4.2 Global Anti Psoriasis Price (2013-2018)

10.5 Anti-acne  Sales Growth and Price

10.5.1 Global Anti-acne  Sales Growth (2013-2018)

10.5.2 Global Anti-acne  Price (2013-2018)

10.6 Others Sales Growth and Price

10.6.1 Global Others Sales Growth (2013-2018)

10.6.2 Global Others Price (2013-2018)

11 Global Dermatological Therapeutics Market Segment by Application

11.1 Global Dermatological Therapeutics Sales Market Share by Application (2013-2018)

11.2 Hospital Sales Growth (2013-2018)

11.3 Clinic Sales Growth (2013-2018)

12 Dermatological Therapeutics Market Forecast (2018-2023)

12.1 Global Dermatological Therapeutics Sales, Revenue and Growth Rate (2018-2023)

12.2 Dermatological Therapeutics Market Forecast by Regions (2018-2023)

12.2.1 North America Dermatological Therapeutics Market Forecast (2018-2023)

12.2.2 Europe Dermatological Therapeutics Market Forecast (2018-2023)

12.2.3 Asia-Pacific Dermatological Therapeutics Market Forecast (2018-2023)

12.2.4 South America Dermatological Therapeutics Market Forecast (2018-2023)

12.2.5 Middle East and Africa Dermatological Therapeutics Market Forecast (2018-2023)

12.3 Dermatological Therapeutics Market Forecast by Type (2018-2023)

12.3.1 Global Dermatological Therapeutics Sales Forecast by Type (2018-2023)

12.3.2 Global Dermatological Therapeutics Market Share Forecast by Type (2018-2023)

12.4 Dermatological Therapeutics Market Forecast by Application (2018-2023)

12.4.1 Global Dermatological Therapeutics Sales Forecast by Application (2018-2023)

12.4.2 Global Dermatological Therapeutics Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Dermatological Therapeutics Picture

Table Product Specifications of Dermatological Therapeutics

Figure Global Sales Market Share of Dermatological Therapeutics by Ty

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery